Recent Posts
- TALLC issues new Corporate Presentation
- Dr. Damon Smith at Biotech Show Case
- TALLC at the Ophthalmology Innovation Summit
- TALLC Corporation Announces Grant of New SmartCelle Patent for Enhanced Ocular Delivery of TA-A001
- Tetra Bio-Pharma and Altus Formulation Form New Company “TALLC” to Exploit TA-A001
TALLC to Present at ChinaBio
See our updated presentation describing TA-A001 for neovascular disease, wound healing and new ocular bio-distribution data
https://informaconnect.com/chinabio-partnering/